AXL and acute myeloid leukemia: Later, it was even demonstrated that AXL inhibition with Axl-Fc substantially reduced resistance to the FLT3 inhibitors midostaurin and quizartinib using MOLM-13 FLT3-ITD+ AML cells [111].